Terry Williams: To those who stayed and accepted change – Thanks
Terry Williams, Professor and Chair of the Department of Radiation Oncology at the City of Hope, shared on X/Twitter:
“I am very proud of our progress. Much has changed in the last 2-3 years and we have grown so fast as an organization. Clinically, major growth in SoCal with 28-33% increases in gross revenues and wRVU productivity, with significant increases in treatment starts.
All the while, maintaining extremely high levels of operational efficiency. On the academic side, we have seen year-over-year growth in research funding (>90% growth in the last 3 years), Radonc PI-led clinical trials (209% growth), and trial accruals by RadOncs (222% growth).
Not to mention many new faculty PI funded clinical trials. Growth in publications, 100s per year with >25% increase in median impact factor. Investments in unification of our RT planning software and hardware, roll-out of auto-segmentation, common EMR, and SGRT programs.
Together with our conceptual integration and standardization through our new Radonc Disease Teams, and quality programs (ASTRO APEx, toxicity reporting, peer review): All serves to enhance collaboration, efficiencies, and connectivity.
Proud that our Press-Ganey patient satisfaction scores are higher than the average for City of Hope (94%tile vs 89%tile). Changes to our residency program, and growth of our RTT programs highlights our commitment to education.
We have started to leverage our vast RadOnc Network across 4 counties including LA, Orange, Riverside, and SB). The addition of our new centers in Phoenix, Atlanta, and Chicago will further boost our missions.
Thankful for M Caligiuri, J Walker, R Stone, S Rosen, V Trisal, V Jensen, A Lee, J Trent, Edward S. Kim, many others for providing the opportunity to transform City of Hope – Department of Radiation Oncology. Very appreciative of our internal leadership team (Louis M, Phyllis B, A Liu, L Botnick, Milt H, Kim H)as well.
Also many tanks to our tremendous team of admin directors, physicians, physicists, nurses, dosimetrists, therapists, schedulers, and more. I look forward to further building upon our successes with our new President of NMC Marcel van den Brink and new CSO/CCC Director Dr. John Carpten.
So honored by the many faculty who have joined me on this ride: Percy Lee, J Bazan, R Li, Heather McGee, Stephanie Yoon, Y Liu, S Maroongroge, A Schwer, B Eastman, T Lim, P Wu, N Cote, April V, Borna M, Bo Liu, T DeWees, and so many more. To those who stayed and accepted change – Thanks.
Lots of excitement to come, with launch of real-time BgRT (SCINTIX) and CT/MRI adaptive programs, and continuing innovation in theranostics, radiogenomics, radioimmunomodulation, and TMLI/TMI.
We will also leverage our National RadOnc Network for clinical trials, our clinical registry/database for research and quality, and PRO/QOL studies. The future is bright sun and I look forward to see what we can further accomplish as a team, succeeding together!”
Source: Terry Williams/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023